Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
Study Identifier
S187.3.003
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
30+ years
Protocol Summary
Long term safety and efficacy (12 months) of levodopa-carbidopa intestinal gel.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 45869
Birmingham, Alabama, United States, 35222
Status
Not applicable
Location
Site Reference ID/Investigator# 45834
Fountain Valley, California, United States, 92708
Status
Not applicable
Location
Site Reference ID/Investigator# 45854
Los Angeles, California, United States, 90033
Status
Not applicable
Location
Site Reference ID/Investigator# 45856
Oceanside, California, United States, 92056
Status
Not applicable
Location
Site Reference ID/Investigator# 45859
Washington D.C., District of Columbia, United States, 20007
Status
Not applicable
Location
Site Reference ID/Investigator# 45857
Bradenton, Florida, United States, 34205
Status
Not applicable
Showing {first} - {last} of {total} Results